Corporate sustainability for architecture engineering and construction (AEC) organizations: Framework,transition and implication strategies

This research aims to propose a regenerative sustainability framework for AEC organizations, not only to focus on delivering green certified projects, but to encourage a revitalized approach to systematically drive their sustainability initiative. To achieve this aim, the study conducts an extensive global review of sustainable assessment systems in various industries and organizations, such as corporate sustainable reports, green company competitions, and green-renowned stocks. After learning the best practices from other industries, a sustainable development framework for the AEC organizations is developed. The proposed framework constitutes 110 key indicators covering three-dimensions of sustainability—social, environmental, and economic, respectively—and four-elements of corporate development essentials—projects, operations, governance, and stakeholders. By comparing the proposed framework to existing AEC practices, the study identifies the skewed development of corporate sustainability in the AEC industry where much awareness have been given to project-level environmental matters, but the social dimension, such as social stakeholders and social governance, are seriously lacking and need to be prioritized. A case study of a multi-millions construction company in China was investigated to validate this framework in practice. The case analysis justifies the practical value of the proposed framework, and elaborates the future need of regenerative sustainable initiatives for AEC organizations. The study contributes to the development of corporate sustainability theory in the AEC industry, and also provides industrial practitioners and policy makers with a better understanding of the next generation of corporate sustainable performance and implementation strategies.     

Potential products from the highly diverse and endemic macroalgae of Southern Australia and pathways for their sustainable production

Macroalgae provide a substantial and renewable resource that can be sustainably utilized for economic and social benefit. A US$7 billion global industry already exists for macroalgae, but the huge majority of this is based on the production of species belonging to approximately six genera, within eight countries, for the manufacture of foods, industrial biomaterials and agricultural products. However, seaweed-derived functional products spanning numerous chemical classes have been identified with valuable therapeutic and industrial applications. This review focuses on the breadth of valuable bioproducts that could be produced from the seaweeds of Southern Australia—a hotspot for seaweed diversity, and the pathways available for their sustainable commercial production. This region contains among the highest level of recorded macroalgal diversity and endemism in the world, with approximately 1,200 described species, of which 62 % are considered endemic. Whilst a number of these species have been shown to be rich sources of higher-value functional products, and most of them still await exploration in this field, the seaweed industry of Southern Australia is largely limited to the harvest of beach-cast biomass for the manufacture of lower-value commodities such as fertilizer and animal feed. There is potential for the development of a substantial industry based on human functional products from seaweeds in Southern Australia. However, a number of challenges and knowledge gaps—including environmental, technological, agronomic, political, and cultural factors—are identified in this review, which must be addressed before sustainable expansion can be achieved. Furthermore, numerous strategic approaches and areas of suggested foci are underscored for research bodies and industry alike. Particular emphasis is given to the need for comprehensive surveying and bioprospecting of the resource; a focus on advanced downstream processing capabilities for improving production efficiency and enhancing product value; the use of biorefinery approaches to improve utilisation efficiency; and pursuing means of improving the sustainability of supply chains.     

生物医药专利密集型产业发展现状及建议*——以上海市为例

目的: 就上海生物医药产业的产业发展现状及专利情况,基于宏观数据分析,提出相应的建议。方法: 通过对比国内各省市生物医药产业和专利数据,聚焦分析上海生物医药产业发展现状、经济贡献及专利布局。结果: 我国已初步形成以长三角、环渤海为核心,珠三角、川渝等地区快速发展的产业空间格局,上海生物医药产业中浦东新区则居于领先地位,高校院所是生物医药领域专利的申请主体。结论: 上海应优化产业承载空间,强化发展要素集聚,深入推进从“点状突破”到“链式创新”,建设生物医药集聚区,加快技术研发与产业化落地。     

生物医药专利密集型产业发展现状及建议*——以上海市为例

目的: 就上海生物医药产业的产业发展现状及专利情况,基于宏观数据分析,提出相应的建议。方法: 通过对比国内各省市生物医药产业和专利数据,聚焦分析上海生物医药产业发展现状、经济贡献及专利布局。结果: 我国已初步形成以长三角、环渤海为核心,珠三角、川渝等地区快速发展的产业空间格局,上海生物医药产业中浦东新区则居于领先地位,高校院所是生物医药领域专利的申请主体。结论: 上海应优化产业承载空间,强化发展要素集聚,深入推进从“点状突破”到“链式创新”,建设生物医药集聚区,加快技术研发与产业化落地。     

Understanding the Rise of Consumer Ethnography: Branding Technomethodologies in the New Economy

ABSTRACT   In this article, I aim to contribute to the ongoing discussion on the changing public role of anthropology by exploring the rise of branded ethnographic practices in consumer research. I argue that a juncture in the "New Economy"—the conjoining of corporate interest in branding, technology, and consumers, with vast social changes—may explain the rapid growth of ethnography for consumer research and predict its future direction. An analysis of branded propaganda from ethnographic vendors that claim their technology-enhanced methods innovate "classic" anthropological practices discloses the way corporations employ technologically mediated means to focus on the reflexive self in consumer research. In this analysis, I reveal that technological methodologies are central to the production of branded ethnographic practices, as forms of branding and technology legitimate consumer–corporate flows of interaction. The conclusion raises awareness to the ways in which modern branding practices reconstruct anthropology in public discourse. [Keywords: branding, consumer research, ethnography, reflexivity, technology]     

区域生物医药产业基于钻石模型的竞争力研究——以石家庄为例

以波特的钻石模型为基础,根据生物医药产业的特点形成了六因素钻石模型的分析框架。以石家庄为例,对影响产业竞争力的生产要素、需求要素、相关和支持性产业要素、企业战略结构和竞争要素、政府、创新这六个要素进行了分析。并对提升产业竞争力的路径进行了阐释,通过发挥比较优势,因地制宜选择合适的产业集群发展模式,积极推进"政产学研医"结合,多种手段搞好创新,积极承接生物制药产业外包服务,加强中介、信息等产业支撑建设,搞好社会文化对生物医药产业的支撑等,保证石家庄生物医药产业的可持续发展。     

A historical perspective on the engineering ideologies of sustainability: the case of SLCA

Purpose

The 1990s produced two distinct engineering ideologies of sustainability—one emphasizing engineering innovation and the other emphasizing socio-cultural change. The technological change ideology of sustainability refers to engineering reform controlled and directed by engineers themselves—in other words, technological practices can be improved through the application of expertise. The technopolitics’ ideology of sustainability is about engineering challenge; it places more emphasis on the devolution of expertise from the existing model of engineering and society, and it questions the dominant values of engineering practice. In this article, I present a historico-philosophical perspective on the development of social life cycle assessment (SLCA) to highlight how the dialectic between sustainability and engineering has been defined largely by the ideology of technological change.

Methods

I provide original historical evidence regarding the roles of key actors and institutions in fitting the life cycle perspective and corporate social responsibility (CSR) into sustainable development. Primary data for this chapter is based on archival materials as well as on 30, in depth, semi-structured interviews with North American and European LCA and SLCA experts. Other primary data were collected from participant observation in SLCA webinars and workshops.

Results and discussion

Technology is at the heart of SLCA—it is a shared faith in technology as the solution. At the same time, there is growing appreciation amongst SLCA proponents that such technology must be construed more critically. Although it remains a subaltern current within LCA, SLCA is evidence of how technological change and technopolitics are starting to converge and influence each other—a probe toward a more reflective form of engineering discourse and toward the formation of a new hybrid sustainability ideology.

Conclusions

SLCA, I argue in this article, is an ideological hybrid where there are many spots of dissent and disagreement but also some surprising fundamental alignments between those who see engineering as techniques and those who believe that engineering needs to be socially and politically contextualized. Yet, even as the concepts of sustainable development, CSR, and LCA provide the intellectual and institutional mold within which SLCA becomes conceivable, these concepts may also obscure the historicity of sustainability engineering.

     

Regulatory affairs and biotechnology in Europe. I. Introduction into good regulatory practice

The high cost and risks associated with the research and development of new drugs demand an alert as well as realistic legislative policy at both national and international levels. Registration of a new drug required before a marketing license is granted, is important for all branches of the pharmaceutical industry but is crucial for success in the innovative biotechnological sector. Innovation as such is no guarantee to be profitable. Increasing government demands have introduced uncertainty on whether new products will secure registration and have led to a disproportionate increase in the economical risks for innovative industry. Preparation and submission of an application for registration should be undertaken seriously and professionally since it has significantly more consequences than simply obtaining a marketing licence. It will influence marketing strategies and results. It is proposed--since dealing with regulatory affairs can be considered as an essential specialism--to apply a Quality Assurance approach. Activities in this context should comply with the same performance standards as developed for GMP, GLP and GCP leading to Good Regulatory Practice (GRP). By acknowledging regulatory affairs as a quality assurance means one can define a set of standard procedures within an organization to ensure that decisions are made on current and future regulations. In such a setup regulatory affairs becomes a marketing tool. This paper illustrates the complex problems found in registration activities. It underlines the necessity of introducing a GRP-approach of performance resulting in substantive evidence of regulatory efficacy.     

IMPACT OF ALGAL RESEARCH IN AQUACULTURE

Algal aquaculture worldwide is estimated to be a $5–6 billion U.S. per year industry. The largest portion of this industry is represented by macroalgal production for human food in Asia, with increasing activity in South America and Africa. The technical foundation for a shift in the last half century from wild harvest to farming of seaweeds lies in scientific research elucidating life histories and growth characteristics of seaweeds with economic interest. In several notable cases, scientific breakthroughs enabling seaweed-aquaculture advances were not motivated by aquaculture needs but rather by fundamental biological or ecological questions. After scientific breakthroughs, development of practical cultivation methods has been accomplished by both scientific and commercial-cultivation interests. Microalgal aquaculture is much smaller in economic impact than seaweed cultivation but is the subject of much research. Microalgae are cultured for direct human consumption and for extractable chemicals, but current use and development of cultured microalgae is increasingly related to their use as feeds in marine animal aquaculture. The history of microalgal culture has followed two main paths, one focused on engineering of culture systems to respond to physical and physiological needs for growing microalgae and the other directed toward understanding the nutritional needs of animals—chiefly invertebrates such as mollusks and crustaceans—that feed upon microalgae. The challenge being addressed in current research on microalgae in aquaculture food chains is to combine engineering and nutritional principles so that effective and economical production of microalgal feed cultures can be accomplished to support an expanding marine animal aquaculture industry.     

Does directed technological change get greener: Empirical evidence from Shanghai's industrial green development transformation

The degree of technological change biased to the environmental factor is crucial to industrial sustainable development. Using the stochastic frontier analysis method based on the translog production function and the panel data of 32 industrial sub-sectors in Shanghai over 1994–2011, this paper combines the evolution dynamic of the frontier technological structure with the evolution dynamic of technological change direction to estimate the output elasticities of production factors and the growth rate of green total factor productivity. Also, we investigate and compare the degrees of technological change biased to four production factors, i.e., capital, labor, energy, and carbon emissions. The results show that the industrial green total factor productivity in Shanghai presents an overall upward trend and mainly depends on the technical efficiency change. The improvements of labor productivity, R&D intensity, and energy efficiency can effectively enhance the green technical efficiency, while capital deepening has a mitigation effect on the green technical efficiency. The technological change of Shanghai's industrial production biases to energy use and capital saving, causing a high energy demand of industrial development. Under the dual impacts of economic development and energy-saving and emission-reduction policies, the degree of technological change biased to the environmental factor (carbon emissions) displays strong and weak alternations, indicating that the green bias of industrial technological change in Shanghai is not stable and that the green transformation of industrial development model needs to be further advanced.     

Analytical laboratory: world class distinction with world-wide connection; from managing instrumentation to managing knowledge

A recent article [F.R. Antonucci, D.A. Barnett, The changing corporate analytical laboratory, CHEMTECH, October 1998] forecasts a change in the way corporate analytical laboratories will operate. At Champion International's Applied Technologies corporate analytical laboratory, this revolutionary change is a movement away from the traditional culture of complete reliance on in-house expertise and instrumentation. Instead, customer needs will be addressed through a network of resources that leverage the both in-house and noncorporate instruments and expertise. We have coined the term “virtual laboratory” for this new laboratory paradigm. This revolution requires the role of corporate analytical scientists to change from one of data and information generators to one of knowledge workers. Associated with this role change is the potential for a dramatic increase in the value of the chemist's contribution to the company, an opportunity for them to function as important business partners with the manufacturing sites and product development centers. The laboratory knowledge workers, the customers, and the virtual laboratory must all work synchronously around prenegotiated expectations regarding cost, quality, and timeliness. The mechanism allowing this change is a Lotus Notes database entitled the Testing Connection. In fact, this database can be viewed as the cornerstone of the virtual laboratory concept. This database allows for the capture of data, information, and knowledge and for collaborative problem solving. All of these capabilities result in faster and better action on customer issues. Also, the migration from problem solving to problem prediction and prevention is achievable.     

Biosimilars advancements: Moving on to the future

Many patents for the first biologicals derived from recombinant technology and, more recently, monoclonal antibodies (mAbs) are expiring. Naturally, biosimilars are becoming an increasingly important area of interest for the pharmaceutical industry worldwide, not only for emergent countries that need to import biologic products. This review shows the evolution of biosimilar development regarding regulatory, manufacturing bioprocess, comparability, and marketing. The regulatory landscape is evolving globally, whereas analytical structure and functional analyses provide the foundation of a biosimilar development program. The challenges to develop and demonstrate biosimilarity should overcome the inherent differences in the bioprocess manufacturing and physicochemical and biological characterization of a biosimilar compared to several lots of the reference product. The implementation of approaches, such as Quality by Design (QbD), will provide products with defined specifications in relation to quality, purity, safety, and efficacy that were not possible when the reference product was developed. Actually, the need to prove comparability to the reference product by the biosimilar industry has increased the knowledge about the product and the production‐process associated by the use of powerful analytical tools. The technological challenges to make copies of biologic products while attending regulatory and market demands are expected to help innovation in the direction of attaining more productive manufacturing processes. © 2015 American Institute of Chemical Engineers Biotechnol. Prog., 31:1139–1149, 2015     

Regulatory affairs and biotechnology in Europe

The high cost and risks associated with the research and development of new drugs demand an alert as well as realistic legislative policy at both national and international levels. Registration of a new drug required before a marketing licence is granted, is important for all branches of the pharmaceutical industry but is crucial for success in the innovative biotechnological sector.Innovation as such is no guarantee to be profitable. Increasing government demands have introduced uncertainty on whether new products will secure registration and have led to a disproportionate increase in the economical risks for innovative industry. Preparation and submission of an application for registration should be undertaken seriously and professionally since it has significantly more consequences than simply obtaining a marketing licence. It will influence marketing strategies and results. It is proposed — since dealing with regulatory affairs can be considered as an essential specialism — to apply a Quality Assurance approach. Activities in this context should comply with the same performance standards as developed for GMP, GLP and GCP leading to Good Regulatory Practice (GRP).By acknowledging regulatory affairs as a quality assurance means one can define a set of standard procedures within an organization to ensure that decisions are made on current and future regulations. In such a setup regulatory affairs becomes a marketing tool.This paper illustrates the complex problems found in registration activities. It underlines the necessity of introducing a GRP-approach of performance resulting in substantive evidence of regulatory efficacy.     

新型冠状病毒肺炎疫情对辽宁省食用菌产业的影响及应对措施

概述了新型冠状病毒肺炎疫情期间辽宁省食用菌产业生产和管理现状,分析了疫情对辽宁省食用菌产业产前、产中、产后的影响,指出了原辅料准备、菌种(棒)生产、养菌管理、产品销售以及人员用工、交通物流等存在的诸多问题,明确了疫情对食用菌产业结构、销售市场结构、投资市场结构主要的影响因素,提出了应对交通不畅、劳动力匮乏、资金短缺、技术缺乏的具体措施,并对辽宁省食用菌产业健康持续高质量发展提出建议。     

Whey valorisation: A complete and novel technology development for dairy industry starter culture production

Whey is the major by-product of the dairy industry, produced in large quantities and usually disposed off causing major environmental pollution, due to its high organic load that makes treatment cost prohibitive. This paper comprises a contribution on the valorisation of this high polluting liquid waste of the dairy industry, based on research for the production of novel dairy starter cultures using whey as raw material. Starter cultures are used for cheese ripening in order to: (i) accelerate ripening, (ii) improve quality and (iii) increase shelf-life. The developed technology involves biomass production from whey followed by thermal drying of cultures. Specifically, Kluyveromyces marxianus, Lactobacillus bulgaricus and kefir yeasts were thermally dried, and their efficiency in lactose and milk whey fermentations was studied. The most suitable culture regarding its technological properties was kefir, which was used for cheese ripening in freeze-dried and thermally dried form. Besides the reduction of production cost, which is an essential requirement for the food industry, the use of thermally dried kefir displayed several other advantages such as acceleration of ripening, increase of shelf-life, and improvement of hard-type cheese quality.     

Physicians and the pharmaceutical industry: a dysfunctional relationship

The pharmaceutical industry is one of the largest and most profitable industries in the world, and in the United States, the industry has a particularly privileged economic position. Yet the cost of drugs in the United States is higher than anywhere else, due largely to the fact that the industry is focusing increasingly on marketing rather than on the development of meaningful new medications: available evidence does not support claims of great expense for the development of new drugs. Because of its vast resources, the pharmaceutical industry has assumed an increasing influence in medicine, which, given the differences in values and priorities between medicine and the drug companies, is a cause for concern. The pharmaceutical industry has acted to maximize its profits in ways that frequently conflict with medicine's need for truth and full disclosure. Indeed, the industry has arguably worked to compromise physicians' judgments, as well as academic standards. As a result, despite government regulation there have been unnecessary adverse effects from drugs. The experience with butorphanol (Stadol) exemplifies problems in the current system and the harm that can result. Changes are suggested to make the pharmaceutical industry more responsive to the needs of patients and physicians.     

Technologies of immortality: the brain on ice

One of the first envatted brains, the most cyborgian element of J. D. Bernal’s 1929 futuristic manifesto, The world, the flesh and the the devil, proposed a technological solution to the dreary certainty of mortality. In Bernal’s scenario the brain is maintained in an ‘out of body’ but ‘like-body’ environment—in a bath of cerebral–spinal fluid held at constant body temperature. In reality, acquiring prospective immortality requires access to very different technologies—those that allow human organs and tissues to be preserved in a quite ‘inhuman’ life-world—the cryogenic storage chamber. Like Bernal, today’s cryonicists consider that immortality can be secured through preservation of the brain alone. In this article I trace attempts to preserve or suspend life, and especially brain function, through the application of new ‘technologies of immortality’. Drawing together historical information on the development of refrigeration, cryopreservation, transplantation, and nanotechnologies, I explore the uneasy relationship between cryonics and the technology on which it depends for its success—cryogenics. In so doing, I argue that the ability to successfully realize the science fiction fantasy of human immortality will rest on a moral and scientific parasitism: the capacity to use the biotechnological artifacts or proxies—cryogenically preserved brains, archived brains, tissues, and immortalized cell lines—derived from the dead, in order to prolong life.     

Development of arbuscular mycorrhizal biotechnology and industry: current achievements and bottlenecks

Advanced scientific knowledge on arbuscular mycorrhizal symbioses recently enhanced potential for implementation of mycorrhizal biotechnology in horticulture and agriculture plant production, landscaping, phytoremediation and other segments of the plant market. The advances consist in significant findings regarding:—new molecular detection tools for tracing inoculated fungi in the field;—the coexistence mechanisms of various fungi in the single root system;—new knowledge on in vitro physiology of the AM fungi grown in root organ cultures;—mechanisms of synergistic interactions with other microbes like PGPR or saprotrophic fungi; discovery of mycorrhiza supportive compounds such as strigolactones. Scientific knowledge has been followed by technological developments like novel formulations for liquid applications or seed coating, mycorrhiza stimulating compounds or new application modes. Still the missing components of biotechnology are appropriate, cheap, highly reproducible and effective methods for inocula purity testing and quality control. Also there is a weak traceability of the origin of the mycorrhizal fungi strains used in commercial inocula. Numerous poor quality products can still be found on the markets claiming effective formation mycorrhiza which have very low capacity to do so. These products usually rely in their effects on plant growth not on support of host plants via formation of effective mycorrhizal symbiosis but on fertilizing compounds added to products. There is growing number of enterprises producing mycorrhiza based inocula recently not only in developed world but increasingly in emerging markets. Also collaboration between private sector and scientific community has an improving trend as the development of private sector can fuel further research activities. Last but not least there is apparent growing pull of the market and increasing tendency of reduction of agrochemical inputs and employment of alternative strategies in planting and plant production. These circumstances support further developments of mycorrhizal inocula production and applications and maturation of the industry.     

A New LCA Methodology of Technology Evolution (TE-LCA) and its Application to the Production of Ammonia (1950-2000) (8 pp)

Goal, Scope and Background

This paper presents a new LCA method of technology evolution (TE-LCA), and its application to the production of ammonia, the second largest chemical product in the world, over the last fifty years. The TE-LCA of a chemical process is the procedure in which historical information on a process, mainly the evolution of technical parameters, is translated by simulation to mass and energy balances as a function of time. These mass and energy balances are then transformed into environmental impact indicators using common LCA approaches. Finally, the evolution of environmental impact resulting from the investigated process can be related to its technical and other, i.e. legislative, developments.

Methods

The technological evolution of the production of ammonia was compiled according to three basic sources of information: patents, publications and industry data. From these sources in a first step, the major technological advances of the process were identified as a function of time delivering different process variants that were modelled using the simulation software Aspen Plus®. In a second step, the evolution of environmental regulations is studied. For those energy related emissions that were regulated, e.g. SOx and NOx, it was assumed that threshold values defined in legislation were realized immediately. The aggregation of both steps allows the calculation of the emissions resulting from the production (cradle to gate view) of the investigated chemical as a function of time.

Results and Discussion

The application of the TE-LCA to the production of ammonia revealed when and to which extent technological and legislative developments resulted in the reduction of energy related emissions in the production of this chemical compound. Overall, the reduction of emissions from ammonia production was highly influenced by the technological development and only to a lower extent by environmental regulations.

Conclusion

The results obtained from the TE-LCA method is useful to reveal how the environmental performance of a process developed in the past and to identify the reasons for this development. The investigated case study of ammonia production shows that investment in technological development also paid off in terms of being ahead of tightened environmental legislation that might bear potential cost consequences such as carbon dioxide tax.

Outlook

The presented method can be easily extended by including an economic analysis, which provides additional information on why certain technological developments were enforced and which the economic consequences of changes in environmental legislation were. The new methodology has to be applied to additional case studies, i.e. to other chemical sectors than basic chemicals and to other branches than chemicals. In other chemical sectors, toxic emissions from the production process might have to be considered and trade-offs between these and the overall energy consumption might result.     

京津冀农民专业合作社时空演化及影响因素解析

农民专业合作社是推进我国乡村振兴、精准扶贫战略以及实现小农户与农业现代化发展有机衔接的重要力量。基于"过程-格局-机理"思维,对2007—2013年京津冀13个地市种植业、养殖业、供销与农机专业合作社的时空演化特征及其影响因素进行分析。结果表明:京津冀种植业、养殖业、供销与农机专业合作社数量总体上呈逐年增长趋势,合作社数量与增长速度均为种植业养殖业供销农机;种植业与养殖业专业合作社呈现"两核一带"空间格局,供销与农机专业合作社分布的梯度特征明显,合作社数量为中部南部北部,四类农民专业合作社分布均存在明显的空间负相关性;空间误差模型对种植业与供销专业合作社有更好的拟合效果,空间滞后模型对养殖业与农机专业合作社有更好的拟合效果;地理因素、经济发展水平、第一产业发展水平对四类专业合作社的发展均有显著的正向影响;市场需求对种植业、养殖业合作社影响最大,第一产业发展水平对供销、农机合作社影响最大。